Search

Research has shown that quitting tobacco use immediately improves health and that tobacco treatment programs make it easier to quit than going it alone.

… Thursday, October 3, 2024 Smoking cigarettes is known to cause at least 12 different types of cancer — not only  lung cancer and  head and neck cancers , but cancers of the  esophagus ,  pancreas ,  bladder ,  colon ,  rectum ,  cervix , and more. Research has shown that quitting tobacco use immediately

La investigación ha demostrado que dejar el consumo de tabaco mejora la salud de inmediato y que los programas de tratamiento del tabaquismo facilitan dejarlo más que intentarlo por su cuenta.

… Thursday, October 3, 2024 Se sabe que fumar cigarrillos causa al menos 12 tipos diferentes de cáncer, no solo  cáncer pulmonar y de  cabeza y cuello , sino también cáncer de  esófago ,  páncreas ,  vejiga ,  colon ,  recto ,  cuello uterino , entre otros. La investigación ha demostrado que dejar el consumo

Symantha Wilson was crushed when chemotherapy quit fighting her lymphoma — and thrilled when immuno¬therapy beat back the cancer. But why doesn’t immunotherapy help more people? MSK researchers are finding answers.

… Friday, April 1, 2022 Symantha Wilson knows she is one of the lucky ones. The 26-year-old Long Island resident was nearing the end of a six-month chemotherapy regimen for stage 2 Hodgkin lymphoma last June. The treatment had been very effective, wiping out most of the cancer cells. But with just over

More sugar available for immune cells could mean better immune responses against cancer.

… Monday, February 15, 2021 Summary New research from Memorial Sloan Kettering scientists suggests that a way to improve immunotherapy is by altering immune cells’ access to sugar. Cancer cells and immune cells share something in common: They both love sugar. Sugar is an important nutrient. All cells use

Like all researchers, nurse scientists design studies, accumulate data, and publish their findings. Their concentration in nursing means that they’re focused on patient needs, perspectives, and outcomes. Whereas a medical doctor might study how a drug is working, a nurse scientist may take a more holistic view of how a treatment affects a patient’s and their family’s quality of life.

… Friday, January 13, 2023 The mission for Kristen Fessele, PhD, RN, ANP-BC, AOCN, is personal. Her mother had survived cancer. But Dr. Fessele, a nurse scientist at Memorial Sloan Kettering Cancer Center (MSK), wanted to see her more than just survive — she wanted to see her thrive again. Dr. Fessele

Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who will benefit from immune checkpoint inhibitors using only routine blood tests and clinical data.

… Monday, January 6, 2025 Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors — a type of immunotherapy — using only routine blood tests and clinical data. The artificial intelligence–based

Scientists in all stages of their careers gathered recently to hear from Sharon Milgram speak about how attitudes and behaviors that can get in the way of a successful career.

… Tuesday, April 9, 2019 Summary At a recent event, GSK students and scientists from across MSK heard from Sharon Milgram about the importance of perseverance and positivity in a career in science. The Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) offers a range of resources to

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by MSK, Weill Cornell Medicine, and The Rockefeller University identified a vulnerability that opens the door to new treatments.

… Thursday, February 20, 2025 In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center (MSK), Weill Cornell Medicine, and The Rockefeller University identified

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce it has been named to the “Brands that Matter” list by Fast Company.

… Tuesday, October 26, 2021 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce it has been named to the “ Brands that Matter ” list by  Fast Company . The inaugural list celebrates 95 global companies and non-profits that have achieved relevance through cultural impact and social engagement

Learn about new insights into endometrial cancer discovered by MSK experts, including why the growing rates of this cancer are even more dangerous for Black women.

… Tuesday, December 19, 2023 The numbers are stark and deeply troubling. Endometrial cancer — which develops in the lining of the uterus (womb) and is sometimes called uterine cancer — is on the rise in the U.S. In 1987, there were 35,000 cases annually. That number has nearly doubled in 2023 to more than